Shionogi & Co., Ltd. has a beta of 0.23 ... S-554110 a nontuberculous mycobacterial infection; S-337395 for RSV infections; S-892216 for COVID-19 therapeutics; Olorofim for invasive aspergillosis ...

Shionogi & Co., Ltd. engages in the research ... S-554110 a nontuberculous mycobacterial infection; S-337395 for RSV infections; S-892216 for COVID-19 therapeutics; Olorofim for invasive ...

The success of WA's nirsevimab program also contributed to the rollout of a national, $174.5 million RSV immunization program now under way for all pregnant women and newborn babies which hopes to ...

Perspective from Lori Handy, MD, MSCE In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of Belgium, Italy, Spain, the Netherlands ...

The 40-year-old, who's daughter to Sharon and Ozzy Osbourne, said she suffered from a respiratory syncytial virus, also known as RSV. These infections, which typically cause coughs and colds ...

The 40-year-old, who's daughter to Sharon and Ozzy Osbourne, said she suffered from a respiratory syncytial virus, also known as RSV. These infections, which typically cause coughs and colds ...

A digital therapeutic (DTx) for attention deficit hyperactivity disorder (ADHD) developed by Akili has been approved in Japan, where it will be sold by licensee Shionogi. The DTx – known as ...

The rollout of a vaccine for respiratory syncytial virus (RSV) has slashed hospital admissions by 30% among older people, according to early data. The benefits are likely to increase as more ...

Digital health company Akili is on the brink of its first major expansion beyond the US, partnering with Shionogi to file a localised version of its attention deficit hyperactivity disorder (ADHD ...

Made by Japanese pharmaceutical firm Shionogi, ensitrelvir is approved in Japan for the treatment of mild to moderate ...